Dr. Cory J. Lappin is a native of New Philadelphia, Ohio and received his Bachelor of Science degree from Miami University, graduating Phi Beta Kappa with Honors with Distinction. He earned his Doctor of Optometry degree from The Ohio State University College of Optometry, where he concurrently completed his Master of Science degree in Vision Science. At the college he served as Class President and was a member of Beta Sigma Kappa Honor Society. Following graduation, Dr. Lappin continued his training by completing a residency in Ocular Disease at the renowned Cincinnati Eye Institute in Cincinnati, Ohio.
Dr. Lappin has been recognized for his clinical achievements, receiving the American Academy of Optometry Foundation Practice Excellence award. He has also been actively engaged in research, being selected to take part in the NIH/NEI T35 research training program and receiving the Vincent J. Ellerbrock Memorial Award in recognition of accomplishments in vision science research.
Dr. Lappin practices at Phoenix Eye Care and the Dry Eye Center of Arizona in Phoenix, Arizona, where he treats a wide variety of ocular diseases, with a particular interest in dry eye and ocular surface disease. He is a Fellow of the American Academy of Optometry, a member of the American Optometric Association, and serves on the Board of Directors for the Arizona Optometric Association. He is also a member of the Tear Film and Ocular Surface Society (TFOS) and volunteers with the Special Olympics Opening Eyes program.
Learn more about Oxervate®, the first FDA-approved medication indicated for the treatment of NK.
By properly identifying and diagnosing Demodex blepharitis, you will be able to treat the underlying cause of several ocular surface disorders triggered by mite infestation. Learn everything you need to know about this complex condition.
Restasis has been a go-to eye drop for dry eye disease for two decades. We interviewed four optometrists to see how they felt about the newly FDA-approved generic version of cyclosporine ophthalmic emulsion 0.05%, and this what they had to say.
Missed Eyes On 2022? You can still catch some of the top sessions from the largest virtual event of the year for ECPs. From updates in presbyopia and orthokeratology to innovations in MIGS, this year’s event was packed with value-rich sessions. Access on-demand recordings from 11 sessions now.
Conjunctivitis affects nearly 6 million people annually in the U.S. and accounts for about 1% of all primary care visits and 28% of ER visits. This comprehensive guide—with downloadable flowcharts—provides the key features to each type to narrow down and reach the ultimate diagnosis.
Ocular Rosacea can have a significant impact on ocular health, appearance, and comfort. Familiarize yourself with the condition and the various treatment options available to optimize patient care.
There is an evolving need for dry eye care and optometrists are on the forefront in terms of managing this chronic and growing condition.